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Abstract 
Background Context: A spinal epidural abscess (SEA) is a serious condition that may be 
managed with antibiotics alone or with decompressive surgery combined with antibiotics.   
Purpose:  The objectives of this study were to assess the clinical outcomes of SEA after surgical 
management and to identify the patient-level factors that are associated with outcomes following 
surgical decompression and removal of SEA. 
Study Design/Setting:  Retrospective chart review analysis. 
Patient Sample:  An analysis of 154 consecutive patients who initially presented to a tertiary-
care, academic medical center with SEA, and were subsequently treated with surgery between 
2010 and 2015 was performed. 
Outcome Measures:  Postoperative pre-discharge American Spinal Injury Association 
Impairment Scale (AIS) scores, 6-month follow-up encounter AIS scores, need for revision 
surgery, and mortality during SEA surgery were the primary outcomes. 
 Physiologic Measures: AIS scores   
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Method:  Fisher's exact and Wilcoxon rank-sum tests were used to assess the associations 
between patient-level factors and surgical outcomes. Moreover, an interactive, predictive model 
for postoperative pre-discharge AIS score was developed using a proportional odds regression 
model.  There was no funding secured for this study and there are no conflict of interest-
associated biases.   
Results:  154 patients (mean age of 58 years) were treated using surgical decompression in 
addition to antibiotics.  The majority of patients were Caucasian (81%) and male (61%).  No 
intraoperative mortality was reported.  A second SEA surgery was performed in 8% of patients.  
A comparison of the preoperative and postoperative pre-discharge AIS scores showed that 49% 
of patients maintained a score of E or improved, while 45% remained at their preoperative status 
and 6% worsened.  Among a subset of patients (n=36; 23%) for whom a 6 month follow-up 
encounter occurred, 75% maintained an AIS score of E or improved, 19% remained at their 
preoperative status, and 6% worsened.  Both the presence and longer duration of preoperative 
paresis was associated with an increased risk of remaining at the same AIS score or worsening at 
the predischarge encounter (both p < 0.001).  A predictive model for predischarge AIS scores 
was developed based on several patient characteristics. 
Conclusions: Surgical decompression can contribute to improving or maintaining AIS scores in 
a high percentage of SEA patients.  The presence and duration of preoperative paresis are 
prognostic for poorer outcomes and suggest that rapid surgical intervention before paresis 
develops may lead to improved postoperative outcomes.  Our modeling tool enables an 
estimation of probabilities of patients‟ predischarge condition.  
 
Keywords: spinal epidural abscess; infection; surgery; paresis; American Spinal Injury Association 
Impairment Scale 
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Introduction 
 
Spinal epidural abscess (SEA) is a pyogenic infection located between the dura mater and the 
bony confines of the spine.
1
 While SEA is a rare occurrence, the potential for serious morbidity 
and mortality is high, with an estimated mortality rate ranging from 1.8-25% and 45% of patients 
suffer from long-term neurologic dysfunction.
2,3,4
  When treated operatively, the most common 
approach is posterior laminectomy with washout of the epidural space.
5
  Though SEA has a high 
potential for morbidity and mortality, to date there are no comprehensive evidence-based criteria 
for predicting the outcomes after treating SEA via operative management.  Several prior studies 
analyzed the risk factors for poor outcomes in patients with SEA, although many of these studies 
focused on medical and surgical management, and no study used a multivariable model that 
included all of the risk factors linked to poor perioperative outcomes specifically.
1,2,4,6-8
 
 
Given the limited number of studies focused on surgical management of SEA, evidence-based 
guidance for managing such patients would prove useful. Therefore, this study sought to 
characterize the clinical outcomes and to identify the patient-level factors that are associated with 
such outcomes following surgical decompression and removal of SEA.  Additionally, we 
attempted to develop an interactive, predictive model for postoperative, predischarge AIS scores.       
  
Methods 
Overview and Study Design 
After obtaining internal review board approval, a retrospective analysis of 154 consecutive 
patients that presented to a tertiary-care, academic medical center with SEA and that were treated 
with any surgery between 2010 and 2015 was performed.  Electronic medical records were 
accessed to gather patient characteristics, imaging studies, and pre/post-surgical neurologic 
status.   
Severity of thecal sac compression was classified into two categories.  If spinal canal 
involvement on the axial view of the magnetic resonance image (MRI) or computed tomography 
(CT) was less than 50%, the compression was judged to be mild to moderate.  If the spinal canal 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
involvement was 50% or greater, then the compression was judged to be severe.  MRI was used 
if both MRI and CT were available.  This approach is the same as the study by Khanna et al.
4
 
 
Study Population 
Any patient younger than 18 years of age was excluded on the basis of skeletal immaturity.  
Additionally, any patients who had spinal malignancy, neuromuscular disease, or Pott‟s disease 
were excluded in order to eliminate the confounding effect of these pathologies.   
 
Outcomes 
The outcomes investigated were postoperative, predischarge American Spinal Injury Association 
Impairment Scale (AIS)
8
 scores, 6 month (± 2 month) follow-up encounter AIS scores, death 
during SEA surgery, and reoperation. AIS scores assess the extent of the spinal injury and can 
range from a value of A (Complete) to E (neurologically intact). Of note, both the achievement 
of good status (levels E/D) and status improvement can be viewed as successful surgical 
outcomes. Therefore, AIS scores were categorized according to both status achievement (levels 
E/D vs. levels C/B/A) and status change (improvement vs. remaining the same/worsening with 
respect to preoperative AIS score).   
 
Analytic Approach 
SEA surgical patient and abscess characteristics are summarized with appropriate descriptive 
statistics (count(%), mean ± standard deviation, or median (Q1 – Q3)). Fisher's exact and 
Wilcoxon rank-sum tests were used to assess the associations between both patient-level and 
abscess-level factors and the categorical version of the AIS outcomes.  A prediction model was 
developed to predict the ordinal outcome of postoperative, predischarge AIS score according to 
preoperative patient factors using a multivariable proportional odds regression model. The 
proportional odds assumption was verified with a score test and a leave-one-out cross-validation 
was performed.  An alpha level of 0.05 was used to determine statistical significance. Analyses 
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were conducted with SAS version 9.4 (SAS Institute, Cary, NC) and R version 3.3.1 (R Core 
Team, Vienna, Austria) statistical software.  
 
Results 
 
Patient Population  
A total of 154 patients (mean age, 58 years) who met the inclusion criteria as described above, 
and their complete demographic data were obtained (Tables 1 and 2).  The majority of patients 
were Caucasian (81%) and male (61%).  Age, race, and sex were not found to be associated with 
predischarge AIS scores (p= 0.61, 0.30, and 0.87, respectively).  See Tables 1 and 2.    
 
Patient Characteristics Associated with Predischarge AIS Scores 
The presence of preoperative paresis was associated with remaining at the same or a worsening 
AIS score at the postoperative predischarge encounter (p < 0.001).  An increasing duration of 
preoperative paresis (mean value of 1 day) was also associated with remaining at the same or a 
worsening AIS score at the predischarge encounter (p<0.001).  Other patient characteristics were 
not associated with unchanged or worsening AIS score at the predischarge encounter compared 
to their preoperative state, though some were relevant in the AIS score prediction model.  See 
Table 2. 
The SEA‟s were found to be located more in the lumbar (28%) and thoracic regions (27%) than 
in the cervical region (21%) with some SEA‟s spanning multiple regions.  Dorsal SEA‟s 
accounted for 41% of the cases and 36% were located ventrally.  Those classified as „other” were 
indeterminate.  Most cases (58%) were categorized as severe thecal sac compression and 34% 
were mild to moderate.  Three of the images were unable to be read due to image quality and for 
10 patients there was no MRI/CT available.  See Table 3.  There was no association found 
between the region of the abscess, the location of the abscess, or the degree of thecal sac 
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compression and the pre-discharge evaluation (p=0.17, 0.13, and 0.39, respectively).  See Table 
4.   
 
Patient Characteristics Associated with Follow-up AIS Scores 
In the subset of patients (n = 36; 23%) for whom a 6 month follow-up evaluation was available, 
the presence of paraspinal abscess, increased preoperative C-reactive protein (CRP), and 
increased preoperative platelets were associated with an increased risk of remaining at the same 
or worsening AIS score at the 6 month follow-up (p=0.02, 0.049, and 0.049, respectively).  See 
Table 2.  The mean time to the post-discharge encounter was 5.7 months.  A significant 
association was found between degree of thecal sac compression and remaining at the same or 
worsening AIS score at the 6 month encounter (p=0.007).  See Table 4. 
 
Pre-discharge and Follow-up AIS Scores 
At the pre-discharge evaluation (mean time from surgery to evaluation 7 days), 79% of patients 
achieved an E or D AIS score while 21% achieved an A, B, or C score.  Among a subset of 
patients (n=36; 23%) for whom a 6 month follow-up encounter occurred, 97% achieved an E or 
D AIS score while 3% achieved an A, B, or C score.  See Table 5. 
A comparison of the preoperative AIS and postoperative pre-discharge AIS scores showed that 
49% of patients maintained an AIS score of E or improved while 45% remained at their 
preoperative status and 6% worsened.  Among a subset of patients (n=36) for whom a 6  month 
follow-up encounter occurred, 75% maintained an AIS score of E or improved, 19% remained at 
their preoperative status, and 6% worsened.  This is summarized in Figure 1.   
 
Death During Surgery and Additional Surgery 
None of the patients died during surgery to treat SEA.  A second surgery was required in 8% (n = 
12) of patients with a mean time between the first and second SEA surgery of 60 days. 
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Postoperative Pre-discharge AIS Score Model 
One aim of this study was to use patient characteristics to create a model that would aid 
physicians in predicting the outcome of treating SEA with surgery.  The study data set contained 
28 preoperative variables, therefore, a reduction process was applied and the final model only 
included variables where R
2
 changed by more than 0.01.  These variables are diabetes, high 
blood pressure, age, paresis, COPD, prior spinal surgery, osteomyelitis, preoperative pain 
duration due to SEA, and preoperative AIS score.   
 
Model Performance 
The concordance index provides a measure of a model‟s ability to discriminate among the levels 
of the outcome, here, the five levels of the predischarge AIS score.  The concordance index is a 
value between 0.5 (coin flip) and 1.0 (perfect ability to rank patients).  Jacknife concordance 
indices were calculated for predischarge AIS scores and resulted in A = 0.98, B = 0.96, C = 0.83, 
D = 0.84 and E = 0.91.  For example, 98% of the time, the predicted probability of a level A 
predischarge AIS score is higher for a patient who achieved a level A predischarge AIS score 
compared to a patient who has any other level (B, C, D, or E). The model displays good 
discrimination capability. 
 
Calibration of Model Predictions 
Leave-one-out cross-validation was used to explore the calibration of the model predictions by 
comparing the proportion of patients predicted to achieve each outcome level versus the actual 
proportion achieving that outcome level.  Since each patient has a range of predicted 
probabilities, the predicted outcome level was taken as the maximum probability in the range. In 
general, if a patient is predicted to achieve a level D or E, then the model is quite good at 
assigning the maximum probability to that level. The model, however, had more difficulty if a 
patient is predicted to achieve the lower levels (A, B, or C) as there was less data available here. 
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Discussion 
 
SEA‟s are associated with significant risk of morbidity and mortality.9-11 To date, there are no 
comprehensive, evidence-based criteria for predicting the outcomes after treating SEA via 
operative management. Although several prior studies analyzed risk factors for poor outcomes in 
patients with SEA, no study used a multivariable model that includes all of the risk factors linked 
to poor perioperative outcomes.
1,2,4,6-8
  Compared to strictly medical management of SEA‟s, 
there are relatively few studies focusing exclusively on surgical and antibiotic management of 
SEA‟s.  Therefore, the objectives of this study were to assess the clinical outcomes of SEA after 
surgical management, to identify patient-level factors that are associated with outcomes 
following surgical decompression of SEA, and to develop a predictive model for determining 
outcomes after surgical intervention.  In the present study, the presence and duration of 
preoperative paresis were associated with remaining at the same or a worsening AIS score at the 
postoperative pre-discharge encounter (p < 0.001) and a predictive model for post-surgical 
outcomes was developed. 
 
Patient Characteristics Associated with Pre-discharge AIS Scores 
In an analysis of 87 patients by Ghobrial et al., the only other study to utilize AIS scores as an 
outcome among SEA patients, the authors found a relative benefit of surgery within 24 hours of 
admission as measured by neurological grade at discharge.
12 
  However, the authors did not 
analyze the relation of paresis to outcome despite finding that all patients who underwent surgery 
within 24 hours of admission had the same or improved AIS score at discharge.  In their study of 
30,274 surgically treated SEA patients, Schoenfeld and Wahlquist found that paralysis of any 
degree was associated with increased risk of morbidity, mortality, and increased cost of 
treatment.
13
  Importantly, the authors did not differentiate between partial and total paralysis.  
Sendi et al. reported in their review of medically and surgically treated SEA patients that if the 
duration of paresis is longer than 24-36 hours, neurological improvement is unlikely and that 
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therefore, prolonged paresis is an indication for decompression surgery.
7
  Patel et al. in their 
study of 128 SEA patients found that neurologic outcomes can be improved through early 
surgical intervention rather than postponing surgery due to attempting medical treatment only.
14
  
There is wide agreement that complete paralysis for more than 24-36 hours is associated with 
very poor outcomes and this characteristic is a relative contraindication to treating these patient‟s 
SEAs surgically.
11,15-19
   
In the present study, both the presence and a mean duration of 1 day of preoperative paresis were 
associated with an increased risk of remaining at the same AIS score or worsening at the 
postoperative encounter (both p < 0.001).  Our findings align with the general trend that delayed 
treatment can lead to poorer outcomes.  The presence of paresis is also a factor in our pre-
discharge AIS score prediction model which adds understanding on the surgical management of 
SEA. 
In 82 patients 50 years and older, Adogwa et al. found that plegia was associated with poor long 
term outcomes.
20
  Similarly, Hlavin et al. reported that 0 out of 7 patients with plegia improved 
after operative management.
17
  Ghobrial et al. found that five out of six patients presenting with 
plegia remained at the same level of plegia at discharge.
12
  These studies are indicative of the 
broader surgical SEA literature: small sample sizes of operative patients leading to inconclusive 
results. The present study also has relatively few patients with plegia, which may limit our ability 
to draw any conclusions about the association between plegia and postoperative outcomes for 
surgical SEA patients. 
 
Pre-discharge and Follow-up AIS Scores 
Connor et al. found 43/55 (78%) of surgically treated patients significantly improved or resolved 
at time of discharge.
21
  The remainder had no improvement, worsened, or died.  Ghobrial et al.‟s 
study found that 62% of patients maintained an AIS score of E or improved at discharge, 33% 
maintained the same score, and 5% worsened.
12
  The same study also showed 79% of surgical 
patients achieved an AIS score of E or D at the time of discharge, though due to small sample 
size and population variation no significant associations could be demonstrated.
12
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A comparison of the preoperative AIS and postoperative pre-discharge AIS scores in the present 
study showed that 49% of patients maintained an AIS score of E or improved while 45% 
remained at their preoperative status and 6% worsened.  At the same pre-discharge evaluation, 
79% of patients achieved an E or D AIS score.  Our data are similar to those reported by 
Ghobrial, though the results of the present study were worse than those in Connor et al.
12,21
 Our 
data suggest that many patients treated with surgery will likely achieve a score of E or improve 
and that a high percentage are likely to be free of or nearly free of weakness at the time of 
discharge.   
Soehle and Wallenfang reported that 60% of patients treated surgically had good outcomes at a 
mean follow-up time of 11 months (good defined as slightly disabled but independently 
ambulatory or without neurological deficit).
8
  Patel et al. found that SEA patients managed 
operatively had an ASIA motor score increase of 9.52 points and a total score of 89.84 out of 100 
at a mean follow-up time of 241.1 days.
14
  Khanna et al. reported 56.7% of surgical patients had 
a “good” outcome and 43.3% had a “poor” outcome measured at mean follow up time of 20.9 
months (range, 4-45 months) (no definitions of “good” or “poor” outcomes were given, mean 
follow-up time was for medically and surgically treated patients in the study).
4
  In a study of 
patients over 50 years old and treated with surgery, Adogwa et al. reported 23% with better 
outcomes, 33% unchanged, 37% worsened or died at mean follow up time of 41.38 +/- 86.48 
weeks (better defined as “neurologically better”).20   
Among a subset of patients (n=36; 23%) for whom a 6 month follow-up encounter occurred, 
75% maintained an AIS score of E or improved, 19% remained at their preoperative status, and 
6% worsened.  At the same encounter, 97% of patients achieved an E or D score.  Comparison to 
other studies with respect to outcomes is made difficult due to variation in grading outcomes and 
time of follow-up measurement.  Data on AIS scores at discharge and longer term follow-up may 
be useful in counseling patients on expectations of outcome when treating SEA with surgery. 
Therefore, further research that follows patients for longer periods postoperatively is warranted 
to develop better clinical decision-making and counseling tools. 
 
Death During Surgery and Additional Surgery  
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While death is a possible outcome of SEA, with a mortality rate of 1.8-25% cited in the 
literature, prior studies do not clarify at what stage in the natural history of the condition or 
treatment that death occurred.
3
 Additionally, to the authors‟ knowledge, no prior studies 
investigated the need for additional surgeries to treat SEA.   
None of the 154 patients in the present study died in the course of treating SEA with surgery.  In 
8% of the patients in the present study, a second spinal surgery was required to treat the SEA.  
These data may be useful in counseling patients on the risk of surgery, potential for additional 
procedures, and aid in setting expectations.   
 
Postoperative Pre-discharge AIS Score Model 
There are several algorithms and grading schemes related to the treatment of SEA.  Algorithms 
for the management of SEA were developed by Tuchman, Shweikeh, and Koppel, with a focus 
on selecting between medical vs. surgical management.
1,22,23
  Davis‟ decision guideline tool is 
centered on diagnosis of SEA in the Emergency Department.
2
  Khanna‟s grading scheme uses 
age, degree of thecal sac compression, and duration of symptoms to predict a good or poor 
outcome in either medical or surgical management.
4
  To the authors‟ knowledge, there are 
currently no models available, which enable the user to predict an AIS score for surgically 
managed SEA patients.      
Our study data enabled the creation of an interactive model to predict the postoperative 
predischarge AIS score (http://riskcalc.org:3838/AIS_Score/). The model incorporates 
preoperative AIS score, pain duration, age, and status of osteomyelitis, preoperative spinal 
surgery, COPD, paresis, high blood pressure, and diabetes mellitus. Our model is a free web-
based tool that enables the user to enter patient characteristics as outlined above.  It calculates the 
probability that a patient will achieve each of the AIS scores at their pre-discharge evaluation.  
This new capability can be useful for the physician in understanding potential outcomes and in 
patient education.  For example, if a patient currently has an AIS score of E and is unsure of their 
treatment choice, their physician can model the probabilities of their pre-discharge condition 
deteriorating to an AIS of C.  Interestingly, patients with a history of COPD and/or high blood 
pressure have slightly improved probabilities of achieving better AIS scores.  Other algorithms 
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predicting the outcomes of SEA management have been developed, though focus on 
nonoperative management or 90-day mortality.
24-26
 
 
Limitations 
 
The retrospective design of our study limits it with the typical biases in data collection.  The 
study is also not a comparative study comparing two different treatment methods and is therefore 
not randomized.  Our 6 month follow-up data are limited by the lack of follow-up by patients for 
these encounters.  Patients in this sub-set may have been more or less likely to follow-up based 
on their condition, which may have introduced selection bias in those results, particularly for 
patients whose outcomes were more positive neurologically.  Allocation bias may also be a 
factor in that surgery may have been selected in cases where the patient‟s neurological condition 
was worse or imaging indicated a larger abscess.   
 
 
Conclusions 
 
Surgical decompression as part of the management of SEA can contribute to improving or 
maintaining AIS scores in a high percentage of patients.  The presence and duration of 
preoperative paresis are prognostic for poorer outcomes and suggest that rapid surgical 
intervention before paresis develops may lead to improved postoperative outcomes.  Our AIS 
score modeling tool enables physicians to enter patient characteristics and understand the 
probabilities of their pre-discharge condition.   
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Figure Captions 
Figure 1. Preoperative and Postoperative AIS Scores 
 
 
 
Table 1. Characteristics of Spinal Epidural Abscess Surgery Patients 
Patient Characteristics N = 154 
Age, years 58.0 ± 12.8 
White 125 (81%) 
Male 94 (61%) 
Body Mass Index
a
, kg/m
2
 28.2 (24.4 - 33.4) 
Current Smoker 35 (24%) 
Admission Source   
     non-facility point of origin 44 (29%) 
     transfer from a different hospital/facility 96 (62%) 
     clinic referral 12 (8%) 
     emergency room 2 (1%) 
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Radiculopathy 53 (34%) 
Neck/Back Pain 123 (80%) 
Duration of Neck/Back Pain, days 7 (2 - 19) 
Bladder/Bowel Dysfunction 34 (22%) 
Paresis 73 (47%) 
Duration of Weakness, days 0 (0 - 5) 
Plegia 24 (16%) 
Numbness 33 (21%) 
Duration of Numbness, days 0 (0 - 0) 
Paraspinal Abscess 48 (31%) 
Staphylococcus Aureus 71 (46%) 
C-reactive protein (CRP), mg/L 121 (52 - 240) 
White Blood Cells (WBC) Count, (k/microliter) 10.9 (8.2 - 14.7) 
Chronic Steroid Use 12 (8%) 
Bacteremia 81 (53%) 
MRSA 25 (17%) 
Osteomyelitis 76 (49%) 
Platelets, (k/microliter) 294 (214 - 380) 
Prior Spinal Surgery 41 (27%) 
IV Drug Use History 13 (8%) 
Anti-depressants 40 (27%) 
Chronic Renal Failure 16 (10%) 
Other Renal Complications 17 (11%) 
Hepatic Disease 21 (14%) 
Coronary Artery Disease 21 (14%) 
High Blood Pressure 89 (58%) 
Diabetes Mellitus   
     Type I 3 (2%) 
     Type II 46 (30%) 
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Congestive Heart Failure 13 (8%) 
Chronic Obstructive Pulmonary Disease 18 (12%) 
Erythrocyte Sedimentation Rate
b
, mm/hr 76.3 ± 30.4 
a missing for 48 subjects 
b missing for 47 subjects 
descriptive statistics are either count (%), mean ± standard deviation or median (Q1 - Q3) 
 
Table 2. Associations Among SEA Patient Characteristics and Surgical Outcomes 
  Postoperative Predischarge AIS     Postoperative 6 months AIS   
Patient Characteristics Improve Same/Worse p   Improve Same/Worse p 
Count 74 78     27 9   
Age, years 57.3 ± 13.4 58.7 ± 12.4 0.61   57.1 ± 14.9 53.3 ± 8.7 0.25 
White 85% 78% 0.30   89% 78% 0.58 
Male 62% 60% 0.87   52% 78% 0.25 
Body Mass Indexa, kg/m2 28.9 (25.7 - 33.4) 27.6 (23.7 - 34.0) 0.27   29.7 (26.1 - 37.2) 27.5 (26.7 - 30.3) 0.31 
Current Smoker 23% 23% 0.99   38% 33% 0.99 
Radiculopathy 38% 31% 0.40   30% 33% 0.99 
Neck/Back Pain 82% 77% 0.43   74% 89% 0.65 
Duration of Neck/Back Pain, days 8 (3 - 16) 7 (2 - 21) 0.81   8 (4 - 21) 7 (4 - 15) 0.98 
Bladder/Bowel Dysfunction 23% 22% 0.99   15% 22% 0.63 
Paresis 32% 63% 0.0002   59% 56% 0.99 
Duration of Paresis, days 0 (0 - 1) 1 (0 - 7) 0.0003   0 (0 - 6) 1 (0 - 1) 0.72 
Plegia 11% 21% 0.12   15% 22% 0.63 
Numbness 20% 23% 0.70   22% 33% 0.66 
Duration of Numbness, days 0 (0 - 0) 0 (0 - 0) 0.69   0 (0 - 0) 0 (0 - 1) 0.79 
Paraspinal Abscess 34% 29% 0.60   7% 44% 0.02 
Staphylococcus Aureus 43% 49% 0.52   52% 67% 0.70 
C-reactive protein (CRP), mg/L 133 (49 - 239) 93 (53 - 241) 0.74   115 (62 - 194) 312 (246 - 427) 0.049 
White Blood Cells (WBC) Count, (k/microliter) 10.6 (7.9 - 13.7) 11.2 (8.4 - 15.3) 0.22   12.2 (8.5 - 17.8) 15.3 (12.9 - 18.7) 0.46 
Chronic Steroid Use 8% 8% 0.99   8% 0% 0.99 
Bacteremia 52% 55% 0.75   52% 44% 0.99 
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MRSA 14% 19% 0.39   11% 0% 0.56 
Osteomyelitis 43% 55% 0.15   44% 67% 0.44 
Platelets, (k/microliter) 258 (214 - 385) 307 (212 - 377) 0.44   276 (202 - 331) 390 (294 - 459) 0.049 
Prior Spinal Surgery 22% 31% 0.27   30% 11% 0.40 
IV Drug Use History 9% 8% 0.78   11% 11% 0.99 
Anti-depressants 33% 21% 0.13   16% 0% 0.55 
Chronic Renal Failure 7% 14% 0.19   11% 0% 0.56 
Other Renal Complications 11% 12% 0.99   4% 11% 0.44 
Hepatic Disease 14% 14% 0.99   4% 0% 0.99 
Coronary Artery Disease 12% 14% 0.81   7% 11% 0.99 
High Blood Pressure 57% 58% 0.99   52% 22% 0.24 
Diabetes Mellitus     0.61       0.37 
     Type I 1% 3%     0% 11%   
     Type II 27% 32%     22% 22%   
Congestive Heart Failure 5% 12% 0.25   0% 11% 0.25 
Chronic Obstructive Pulmonary Disease 15% 6% 0.11   15% 0% 0.55 
Erythrocyte Sedimentation Rateb, mm/hr 74.1 ± 31.3 78.7 ± 29.6 0.31   77 ± 37 96 ± 13 0.23 
descriptive statistics are either count (%), mean ± standard deviation or median (Q1 - Q3) 
p-values result from either Fisher's exact (categorical) or Wilcoxon rank-sum (continuous)  tests 
AIS = American Spinal Injury Association Impairment Scale scores 
 
Table 3. Characteristics of Spinal Epidural Abscesses 
SEA Characteristics N = 154 
Region of Abscess   
     cervical 33 (21%) 
     cervico-thoraco-lumbar 1 (1%) 
     cervico-thoraco-lumbo-sacral 1 (1%) 
     cervicothoracic 7 (4%) 
     lumbar 44 (28%) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
     lumbosacral 17 (11%) 
     thoracic 41 (27%) 
     thoraco-lumbo-sacral 4 (3%) 
     thoracolumbar 6 (4%) 
Abscess Location   
     dorsal 63 (41%) 
     dorsolateral left 4 (3%) 
     dorsolateral right 3 (2%) 
     left 4 (3%) 
     right 6 (4%) 
     ventral 56 (36%) 
     ventrolateral left 2 (1%) 
     ventrolateral right 6 (4%) 
     other 10 (6%) 
Degree of Compression   
     mild to moderate 52 (34%) 
     severe 89 (58%) 
     unable to read 3 (2%) 
     no MRI/CT 10 (6%) 
 
Table 4. Associations Among Abscess Characteristics and Surgical Outcomes 
  
Postoperative 
Predischarge AIS     
Postoperative                      
6 months AIS   
Patient Characteristics Improve Same/Worse p   Improve Same/Worse p 
Count 54 63     21 5   
Region of Abscess     0.17       0.99 
     cervical 20% 35%     33% 40%   
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     lumbar 44% 30%     24% 20%   
     thoracic 35% 35%     43% 40%   
                
Count 43 46     16 6   
Abscess Location     0.13       0.15 
     ventral 33% 50%     38% 83%   
     dorsal 67% 50%     62% 17%   
                
Count 69 71     24 9   
Degree of Compression     0.39       0.007 
     mild to moderate 33% 41%     67% 11%   
     severe 67% 59%     33% 89%   
p-values result from Fisher's exact tests 
AIS = American Spinal Injury Association Impairment Scale scores 
 
Table 5. Postoperative AIS Scores 
Postoperative Predischarge AIS         
     improvement 74 (49%)   achieved E/D status 120 (79%) 
     stayed same 68 (45%)   achieved C/B/A status 32 (21%) 
     worsened 10 (6%)         
            
Postoperative 6 month AIS         
     improvement 27 (75%)   achieved E/D status 35 (97%) 
     stayed same 7 (19%)   achieved C/B/A status 1 (3%) 
     worsened 2 (6%)         
AIS = American Spinal Injury Association Impairment Scale scores 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Table 6. Classification Table of Predicted and Actual Postoperative, Predischarge AIS Score 
 
  Actual Postoperative Predischarge AIS Score Level 
     A B C D E Total 
Predicted 
Postoperative 
Predischarge AIS 
Score Level 
A 4 (44%) 5 (56%) 0 (0%) 0 (0%) 0 (0%) 9 (6%) 
B 2 (29%) 2 (29%) 3 (43%) 0 (0%) 0 (0%) 7 (5%) 
C 0 (0%) 0 (0%) 4 (50%) 4 (50%) 0 (0%) 8 (5%) 
D 0 (0%) 0 (0%) 8 (11%) 50 (70%) 13 (18%) 71 (49%) 
E 0 (0%) 0 (0%) 1 (2%) 6 (12%) 44 (86%) 51 (35%) 
 
Total 6 (4%) 7 (5%) 16 (11%) 60 (41%) 57 (39%) 146 
 
 
 
